Daniel P. Witt
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Daniel P. Witt
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 | |
Glycan Pharmaceuticals, Inc.
 Glycan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Repligen Corp., Glycan Pharmaceuticals, Inc. is a biopharmaceutical company. The company is based in Cambridge, MA. Glycan Pharmaceuticals was acquired by Repligen Corp. on March 14, 1996.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Daniel P. Witt
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| 908 DEVICES INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| University of Connecticut | College/University | Graduate Degree Director/Board Member | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Graduate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Tufts University | College/University | Undergraduate Degree | |
| Vitivity, Inc. | General Counsel | ||
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VISTERRA INC | Pharmaceuticals: Major | General Counsel | |
| Northeastern University School of Law | College/University | Graduate Degree | |
| The Worcester Foundation for Biomedical Research | Corporate Officer/Principal | ||
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | General Counsel | |
| RUBIUS THERAPEUTICS | Biotechnology | General Counsel | |
| RALLYBIO CORPORATION | Biotechnology | Director of Finance/CFO | |
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MONOPAR THERAPEUTICS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Faculté de Médecine Paris | College/University | Doctorate Degree | |
Thiogenesis Therapeutics, Inc.
 Thiogenesis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thiogenesis Therapeutics, Inc. engages in the development of novel compounds that are based on thiols, thiol derivatives or S-H groups. The company was founded by Patrice P. Rioux and Vincent P. Stanton and is headquartered in Belmont, MA. | Pharmaceuticals: Major | Founder | |
| Pitié-Salpêtrière | College/University | Undergraduate Degree | |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Chief Operating Officer | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| CHECKMATE PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree | |
| VICARIOUS SURGICAL INC. | Medical Specialties | Director of Finance/CFO | |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Director of Finance/CFO | |
Aptuit LLC
 Aptuit LLC Miscellaneous Commercial ServicesCommercial Services Aptuit LLC engages in the development of pharmaceutical and biotechnological products. Its offerings include drug design and discovery, preclinical biosciences, API development and manufacture, solid state chemistry, solid and oral dosage form development and manufacture, integrated drug discovery and drug development, Aptuit INDiGO, and physical and analytical chemistry services. The company was founded in December 2004 and is headquartered in Greenwich, CT. | Miscellaneous Commercial Services | Founder | |
| University of Kansas | College/University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 47 |
| Frankreich | 3 |
| Taiwan | 2 |
| Hong Kong | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 14 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 3 |
Operativ
| Director/Board Member | 97 |
| Corporate Officer/Principal | 65 |
| Director of Finance/CFO | 35 |
| President | 27 |
| Independent Dir/Board Member | 27 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Karen Dawes | 22 |
| Nicolas Barthelemy | 19 |
| Sandy Smith | 19 |
| Jonathan Lieber | 16 |
| John Cox | 15 |
| Michael A. Griffith | 14 |
| William J. Ryan | 14 |
| Robert J. Hennessey | 13 |
| Christopher McNulty | 13 |
| Mark F. Boshar | 13 |
| Daniel Muehl | 12 |
| Patrice Rioux | 12 |
| Earl Webb Henry | 11 |
| Avery Catlin | 11 |
| Glenn L. Cooper | 10 |
- Börse
- Insiders
- Daniel P. Witt
- Unternehmensverbindungen
